News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,435 Results
Type
Article (40217)
Company Profile (338)
Press Release (657880)
Section
Business (207056)
Career Advice (2060)
Deals (35921)
Drug Delivery (94)
Drug Development (82248)
Employer Resources (172)
FDA (16181)
Job Trends (15133)
News (350008)
Policy (32834)
Tag
Academia (2556)
Alliances (50122)
Alzheimer's disease (1286)
Approvals (16143)
Artificial intelligence (148)
Bankruptcy (355)
Best Places to Work (11708)
Biotechnology (240)
Breast cancer (191)
Cancer (1387)
Cardiovascular disease (112)
Career advice (1715)
Cell therapy (287)
Clinical research (65794)
Collaboration (496)
Compensation (267)
COVID-19 (2566)
C-suite (112)
Data (1405)
Diabetes (176)
Diagnostics (6194)
Earnings (85927)
Employer resources (150)
Events (112521)
Executive appointments (403)
FDA (16875)
Funding (433)
Gene therapy (198)
GLP-1 (628)
Government (4376)
Healthcare (18791)
Infectious disease (2659)
Inflammatory bowel disease (113)
Interviews (326)
IPO (16607)
Job creations (3837)
Job search strategy (1465)
Layoffs (433)
Legal (7928)
Lung cancer (199)
Manufacturing (212)
Medical device (13247)
Medtech (13252)
Mergers & acquisitions (19480)
Metabolic disorders (471)
Neuroscience (1614)
NextGen Class of 2024 (6565)
Non-profit (4487)
Northern California (1709)
Obesity (266)
Opinion (200)
Parkinson's disease (99)
Patents (121)
People (57342)
Phase I (20509)
Phase II (29026)
Phase III (21527)
Pipeline (515)
Postmarket research (2572)
Preclinical (8704)
Radiopharmaceuticals (246)
Rare diseases (265)
Real estate (6070)
Regulatory (21972)
Research institute (2336)
Resumes & cover letters (354)
Southern California (1480)
Startups (3652)
United States (15451)
Vaccines (577)
Weight loss (192)
Date
Today (108)
Last 7 days (568)
Last 30 days (2418)
Last 365 days (35845)
2024 (35685)
2023 (40683)
2022 (51812)
2021 (56358)
2020 (54581)
2019 (47021)
2018 (35413)
2017 (32716)
2016 (32119)
2015 (38168)
2014 (32052)
2013 (26961)
2012 (29102)
2011 (29750)
2010 (27754)
Location
Africa (737)
Arizona (198)
Asia (39249)
Australia (6232)
California (3865)
Canada (1463)
China (314)
Colorado (175)
Connecticut (182)
Europe (83166)
Florida (544)
Georgia (136)
Illinois (390)
Indiana (227)
Maryland (646)
Massachusetts (3024)
Michigan (175)
Minnesota (294)
New Jersey (1121)
New York (1097)
North Carolina (791)
Northern California (1709)
Ohio (147)
Pennsylvania (934)
South America (1117)
Southern California (1480)
Texas (563)
Utah (109)
Washington State (407)
698,435 Results for "shanghai zhimeng biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Zhimeng Biopharma CB03 Received Orphan Drug Designation from the US FDA - A Potassium Ion Channel Opener for Amyotrophic Lateral Sclerosis
Shanghai Zhimeng Biopharma, Inc. (“Zhimeng”), announced that one of its innovative small-molecule KCNQ2/3 selective opener compounds (CB03), developed for the treatment of amyotrophic lateral sclerosis (ALS), received orphan drug designation (ODD) from US FDA.
October 20, 2023
·
3 min read
Manufacturing
Biopharma’s Big Question of 2024: Can You Scale It?
Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of pharma is going to be vying for capacity and talent.
December 18, 2024
·
5 min read
·
Annalee Armstrong
Job Trends
5 Biopharma Companies Hiring in New York
Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.
November 21, 2024
·
1 min read
·
Chantal Dresner
Job Trends
BioSpace
Announces 2025 Best Places to Work in Biopharma
BioSpace
has named 50 biopharma companies to its 2025 Best Places to Work list, including Moderna and Sutro Biopharma, whose executives share what makes their organizations special.
November 12, 2024
·
6 min read
·
Angela Gabriel
Press Releases
COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization
December 23, 2024
·
8 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
December 5, 2024
·
1 min read
·
Angela Gabriel
Policy
How Trump’s Immigration Policies Could Affect Biopharma Professionals’ Work Visas
Based on how President-elect Donald Trump’s first administration handled immigration, experts are concerned about how his second term will impact foreign-born biopharma professionals. Two immigration attorneys discuss what may be ahead, including increased difficulty getting work visas.
December 5, 2024
·
6 min read
·
Angela Gabriel
Press Releases
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
November 4, 2024
·
1 min read
Drug Development
Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase -- Clinical Trial of CB06
Shanghai Zhimeng Biopharma, Inc. (“Zhimeng”), announced dosing of the first participant in the US Phase I study of its novel TLR8 agonist (CB06), which is being developed for the treatment of chronic hepatitis B virus infection.
March 31, 2022
·
3 min read
Artificial Intelligence
AI Is Accelerating Biopharma Innovation But Not Erasing a Human’s Touch
Artificial intelligence won’t replace people in biopharma, but it is infiltrating every step of drug development, including in some ways that aren’t so obvious.
October 16, 2024
·
5 min read
·
Annalee Armstrong
1 of 69,844
Next
